Back to Search
Start Over
pfk13 -Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom.
- Source :
-
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Feb 23; Vol. 61 (3). Date of Electronic Publication: 2017 Feb 23 (Print Publication: 2017). - Publication Year :
- 2017
-
Abstract
- We present case histories of four patients treated with artemether-lumefantrine for falciparum malaria in UK hospitals in 2015 to 2016. Each subsequently presented with recurrent symptoms and Plasmodium falciparum parasitemia within 6 weeks of treatment with no intervening travel to countries where malaria is endemic. Parasite isolates, all of African origin, harbored variants at some candidate resistance loci. No evidence of pfk13 -mediated artemisinin resistance was found. Vigilance for signs of unsatisfactory antimalarial efficacy among imported cases of malaria is recommended.<br /> (Copyright © 2017 Sutherland et al.)
- Subjects :
- Africa
Aged
Artemether, Lumefantrine Drug Combination
Drug Combinations
Female
Gene Expression
Genetic Loci
Humans
Malaria, Falciparum parasitology
Malaria, Falciparum pathology
Male
Parasitemia parasitology
Parasitemia pathology
Plasmodium falciparum genetics
Plasmodium falciparum growth & development
Recurrence
Travel
Treatment Failure
United Kingdom
Young Adult
Antimalarials therapeutic use
Artemisinins therapeutic use
Drug Resistance genetics
Ethanolamines therapeutic use
Fluorenes therapeutic use
Malaria, Falciparum drug therapy
Parasitemia drug therapy
Plasmodium falciparum drug effects
Protozoan Proteins genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1098-6596
- Volume :
- 61
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Antimicrobial agents and chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 28137810
- Full Text :
- https://doi.org/10.1128/AAC.02382-16